This weekend ushers in the 25th anniversary of the International Symposium on Endovascular Therapy (ISET) in Miami Beach and launches the 2013 conference season in earnest.
Conferences appear to be an ongoing phenomenon, with worthy events large and small scheduled worldwide. But for me, this year’s ISET sets the routine in motion. The meeting’s capstone is likely to be a session on renal denervation, co-moderated by Barry T. Katzen, MD, course director for ISET and founder and medical director at Baptist Cardiac & Vascular Institute in Miami, and Martin B. Leon, MD, director of the Center for Interventional Vascular Therapy at Columbia University Medical Center/New York-Presbyterian Hospital in New York City.
For a taste of what will be discussed at the meeting, we published an essay by Katzen, which is available here. Stay tuned for coverage as presenters share results from their trials throughout the week.
Another sign that conference season has arrived is the email notices from the American College of Cardiology, whose annual scientific session is scheduled to be in San Francisco March 9 through 11. We will give you a preview of the late-breaking clinical trials—always findings of high interest to our community—in late February, when the ACC will unveil more details about its 2013 lineup.
Drop us a line, whether you are attending these events or not, and let us know if and how they help you in your practice or administration duties. What do you hope to gain from conferences? Do they deliver? For those not at the events, how do you stay abreast of findings that are presented at meetings? Are there ways we can better serve you?
Please email and let me know.
Cardiovascular Business, editor